{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:26:06Z","timestamp":1774416366648,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["942244"],"award-info":[{"award-number":["942244"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09695-8","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:37:10Z","timestamp":1770899830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proof-of-principle of NF1 gene therapy in plexiform neurofibroma xenograft mouse models"],"prefix":"10.1038","volume":"9","author":[{"given":"Dhanushka","family":"Hewa Bostanthirige","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Plante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Gascon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maude","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Deschenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Sabo Vatasescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0994-0042","authenticated-orcid":false,"given":"Benoit","family":"Chabot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Geha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5852-3507","authenticated-orcid":false,"given":"Jean-Philippe","family":"Brosseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"9695_CR1","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1212\/WNL.0000000000005788","volume":"91","author":"JP Brosseau","year":"2018","unstructured":"Brosseau, J. P. et al. The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities. Neurology 91, S14\u2013S20 (2018).","journal-title":"Neurology"},{"key":"9695_CR2","doi-asserted-by":"crossref","unstructured":"Mohamad, T., Plante, C., and Brosseau, J. P. Toward Understanding the Mechanisms of Malignant Peripheral Nerve Sheath Tumor Development. Int. J. Mol. Sci. 22, 8620 (2021).","DOI":"10.3390\/ijms22168620"},{"key":"9695_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07452-y","volume":"9","author":"JP Brosseau","year":"2018","unstructured":"Brosseau, J. P. et al. NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. Nat. Commun. 9, 5014 (2018).","journal-title":"Nat. Commun."},{"key":"9695_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/2159-8290.CD-18-0151","volume":"9","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. Spatiotemporal Loss of NF1 in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway. Cancer Discov. 9, 114\u2013129 (2019).","journal-title":"Cancer Discov."},{"key":"9695_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ccr.2007.12.027","volume":"13","author":"J Wu","year":"2008","unstructured":"Wu, J. et al. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 13, 105\u2013116 (2008).","journal-title":"Cancer Cell"},{"key":"9695_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.1068452","volume":"296","author":"Y Zhu","year":"2002","unstructured":"Zhu, Y., Ghosh, P., Charnay, P., Burns, D. K. & Parada, L. F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296, 920\u2013922 (2002).","journal-title":"Science"},{"key":"9695_CR7","doi-asserted-by":"crossref","unstructured":"Rhodes, S. D. et al. Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation. Hum. Mol. Genet. 28, 2752\u20132762 (2019).","DOI":"10.1093\/hmg\/ddz095"},{"key":"9695_CR8","doi-asserted-by":"crossref","unstructured":"Mo, J. et al. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins. J. Clin. Invest. 131, 1\u201314 (2021).","DOI":"10.1172\/JCI139807"},{"key":"9695_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccell.2014.09.009","volume":"26","author":"Z Chen","year":"2014","unstructured":"Chen, Z. et al. Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma. Cancer Cell 26, 695\u2013706 (2014).","journal-title":"Cancer Cell"},{"key":"9695_CR10","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/labinvest.2016.88","volume":"96","author":"H Li","year":"2016","unstructured":"Li, H., Chang, L. J., Neubauer, D. R., Muir, D. F. & Wallace, M. R. Immortalization of human normal and NF1 neurofibroma Schwann cells. Lab Invest 96, 1105\u20131115 (2016).","journal-title":"Lab Invest"},{"key":"9695_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0002-9440(10)63992-2","volume":"158","author":"D Muir","year":"2001","unstructured":"Muir, D., Neubauer, D., Lim, I. T., Yachnis, A. T. & Wallace, M. R. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am. J. Pathol. 158, 501\u2013513 (2001).","journal-title":"Am. J. Pathol."},{"key":"9695_CR12","doi-asserted-by":"crossref","unstructured":"Zamora, P. O. et al. Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency. Cancers (Basel) 15, 5811 (2023).","DOI":"10.3390\/cancers15245811"},{"key":"9695_CR13","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-03-4079","volume":"64","author":"AO Stemmer-Rachamimov","year":"2004","unstructured":"Stemmer-Rachamimov, A. O. et al. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res 64, 3718\u20133724 (2004).","journal-title":"Cancer Res"},{"key":"9695_CR14","unstructured":"Lucas, C. G. et al. Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis type 1 (NF1). Neuro. Oncol. 27, 616\u2013624 (2025)."},{"key":"9695_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","volume":"67","author":"MM Miettinen","year":"2017","unstructured":"Miettinen, M. M. et al. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. Hum. Pathol. 67, 1\u201310 (2017).","journal-title":"Hum. Pathol."},{"key":"9695_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1101\/gad.862101","volume":"15","author":"Y Zhu","year":"2001","unstructured":"Zhu, Y. et al. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15, 859\u2013876 (2001).","journal-title":"Genes Dev."},{"key":"9695_CR17","doi-asserted-by":"publisher","first-page":"E2421","DOI":"10.1073\/pnas.1522202113","volume":"113","author":"A Kagiava","year":"2016","unstructured":"Kagiava, A. et al. Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy. Proc. Natl. Acad. Sci. USA 113, E2421\u2013E2429 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9695_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-7-63","volume":"7","author":"H Yu","year":"2011","unstructured":"Yu, H. et al. Lentiviral gene transfer into the dorsal root ganglion of adult rats. Mol. Pain. 7, 63 (2011).","journal-title":"Mol. Pain."},{"key":"9695_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1590\/S0021-75572007000800016","volume":"83","author":"LG Darrigo Jr","year":"2007","unstructured":"Darrigo, L. G. Jr et al. Prevalence of plexiform neurofibroma in children and adolescents with type I neurofibromatosis. J. Pediatr. (Rio J.) 83, 571\u2013573 (2007).","journal-title":"J. Pediatr. (Rio J.)"},{"key":"9695_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ng0794-353","volume":"7","author":"T Jacks","year":"1994","unstructured":"Jacks, T. et al. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat. Genet 7, 353\u2013361 (1994).","journal-title":"Nat. Genet"},{"key":"9695_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bbrc.2006.07.159","volume":"348","author":"SL Thomas","year":"2006","unstructured":"Thomas, S. L. et al. Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells. Biochem Biophys. Res Commun. 348, 971\u2013980 (2006).","journal-title":"Biochem Biophys. Res Commun."},{"key":"9695_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41434-019-0080-9","volume":"26","author":"RY Bai","year":"2019","unstructured":"Bai, R. Y. et al. Feasibility of using NF1-GRD and AAV for gene replacement therapy in NF1-associated tumors. Gene Ther. 26, 277\u2013286 (2019).","journal-title":"Gene Ther."},{"key":"9695_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63619-4","volume":"16","author":"RY Bai","year":"2025","unstructured":"Bai, R. Y. et al. Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. Nat. Commun. 16, 8594 (2025).","journal-title":"Nat. Commun."},{"key":"9695_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s10038-022-01072-7","volume":"67","author":"C Wu","year":"2022","unstructured":"Wu, C., Iyer, S., Wolfe, S. A. & Jacobson, A. Functional restoration of mouse Nf1 nonsense alleles in differentiated cultured neurons. J. Hum. Genet 67, 661\u2013668 (2022).","journal-title":"J. Hum. Genet"},{"key":"9695_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114914","volume":"380","author":"C Wu","year":"2024","unstructured":"Wu, C. et al. Investigating therapeutic nonsense suppression in a neurofibromatosis mouse model. Exp. Neurol. 380, 114914 (2024).","journal-title":"Exp. Neurol."},{"key":"9695_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.omtn.2023.06.018","volume":"33","author":"SH Osum","year":"2023","unstructured":"Osum, S. H. et al. Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1. Mol. Ther. Nucleic Acids 33, 227\u2013239 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"9695_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/humu.23681","volume":"40","author":"Y Cui","year":"2019","unstructured":"Cui, Y. & Morrison, H. Construction of cloning-friendly minigenes for mammalian expression of full-length human NF1 isoforms. Hum. Mutat. 40, 187\u2013192 (2019).","journal-title":"Hum. Mutat."},{"key":"9695_CR28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/humu.23421","volume":"39","author":"D Wallis","year":"2018","unstructured":"Wallis, D. et al. Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA. Hum. Mutat. 39, 816\u2013821 (2018).","journal-title":"Hum. Mutat."},{"key":"9695_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-2-r19","volume":"8","author":"J Hellemans","year":"2007","unstructured":"Hellemans, J., Mortier, G., De Paepe, A., Speleman, F. & Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8, R19 (2007).","journal-title":"Genome Biol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09695-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09695-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09695-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:43:49Z","timestamp":1774413829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09695-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9695"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09695-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}